Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mersana Therapeutics, Inc. - Common Stock (NQ: MRSN )

0.5570 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 119,597
Open 0.5570
Bid (Size) 0.5585 (6)
Ask (Size) 0.5620 (7)
Prev. Close 0.5570
Today's Range 0.5570 - 0.5570
52wk Range 0.4913 - 6.280
Shares Outstanding 71,761,525
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?
Mersana shares Phase 1 data on Emi-Le for TNBC and details FDA's Fast Track status for XMT-1660 in advanced HER2-low breast cancer. 
Via Benzinga
Exposures Product Safety

Performance

YTD
-60.21%
-60.21%
1 Month
+1.29%
+1.29%
3 Month
-74.91%
-74.91%
6 Month
-59.93%
-59.93%
1 Year
-84.66%
-84.66%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Earnings Preview For Mersana Therapeutics
Via Benzinga
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
Via Benzinga
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
What To Know About Citigroup's Upgrade of Mersana Therapeutics
Via Benzinga
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
Via InvestorPlace
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
Via PressReach
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
How To Invest In The Healthcare Sector
Via Talk Markets
Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations
Via Benzinga
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.